Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Frenck

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Current Opinion in Pediatrics|March 2, 2022
EditorialRobert W Frenck
Vaccine|August 25, 2016
Response to Letter to the Editor regarding: Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccineKristina Bryant, Robert W Frenck
Journal of Clinical Medicine|January 11, 2024
COVID-19 Vaccines in ChildrenDanielle Fayad, Robert W Frenck
Microbes and Infection|June 20, 2003
Helicobacter in the developing worldRobert W Frenck, John Clemens
Expert Opinion on Biological Therapy|November 15, 2011
The development of 13-valent pneumococcal conjugate vaccine and its possible use in adultsRobert W Frenck, Sylvia Yeh
Adolescent Medicine: State of the Art Reviews|November 5, 2010
Adolescent pneumoniaElizabeth P Schlaudecker, Robert W Frenck
Arthritis Care & Research|May 28, 2010
Varicella vaccine safety and immunogenicity in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroidsRobert W Frenck, Jane F Seward
The New England Journal of Medicine|September 15, 2021
BNT162b2 Covid-19 Vaccine in Adolescents. ReplyRobert W Frenck, Philip R Dormitzer, Alejandra Gurtman
Adolescent Medicine: State of the Art Reviews|November 5, 2010
Infectious diseases and immunizations. PrefacePaula K Braverman, Robert W Frenck, Cynthia Holland-Hall
Clinical Pediatrics|August 8, 2013
Polyarthritis in a 19-year-old female with systemic lupus erythematosusAndrea Hahn, Tracy V Ting, Janalee Taylor, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Current Opinion in Pediatrics|March 2, 2022
EditorialRobert W Frenck
Vaccine|August 25, 2016
Response to Letter to the Editor regarding: Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccineKristina Bryant, Robert W Frenck
Journal of Clinical Medicine|January 11, 2024
COVID-19 Vaccines in ChildrenDanielle Fayad, Robert W Frenck
Microbes and Infection|June 20, 2003
Helicobacter in the developing worldRobert W Frenck, John Clemens
Expert Opinion on Biological Therapy|November 15, 2011
The development of 13-valent pneumococcal conjugate vaccine and its possible use in adultsRobert W Frenck, Sylvia Yeh
Adolescent Medicine: State of the Art Reviews|November 5, 2010
Adolescent pneumoniaElizabeth P Schlaudecker, Robert W Frenck
Arthritis Care & Research|May 28, 2010
Varicella vaccine safety and immunogenicity in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroidsRobert W Frenck, Jane F Seward
The New England Journal of Medicine|September 15, 2021
BNT162b2 Covid-19 Vaccine in Adolescents. ReplyRobert W Frenck, Philip R Dormitzer, Alejandra Gurtman
Adolescent Medicine: State of the Art Reviews|November 5, 2010
Infectious diseases and immunizations. PrefacePaula K Braverman, Robert W Frenck, Cynthia Holland-Hall
Clinical Pediatrics|August 8, 2013
Polyarthritis in a 19-year-old female with systemic lupus erythematosusAndrea Hahn, Tracy V Ting, Janalee Taylor, et al.
Pageof 9